ResMed Tops Expectations but Falls Anyway
Medical-device maker ResMed (NYSE: RMD) reported its fiscal fourth-quarter results after the market closed on Tuesday, Aug. 1. The continuous positive airway pressure (CPAP) pioneer reported modest top-line growth when compared with last quarter, but margin improvements help drive better-than-expected results on the bottom line.
Let's take a closer look at the company's results to get a better sense of how it fared during the period.
Image source: Getty Images.
Source: Fool.com
Resmed Inc. Aktie
204,90 €
3,52 %
Rein positive Einschätzungen für Resmed Inc., nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Ein positives Kurspotenzial für Resmed Inc. ist gegeben, mit einem Kursziel von 215 € über dem aktuellen Kurs von 204.9 €.
